Nektar Therapeutics to discuss alopecia areata trial results
Tweet Send to a Friend
Nektar Therapeutics (NASDAQ: NKTR) will host a conference call on April 20, 2026 at 8:00 a.m. ET to present 52-week ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


